Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice.

Evans, Marc; Morgan, Angharad R; Bain, Stephen C; Davies, Sarah; Hicks, Debbie; Brown, Pam; Yousef, Zaheer; Dashora, Umesh; Viljoen, Adie; Beba, Hannah; Strain, W David

Evans, Marc; Morgan, Angharad R; Bain, Stephen C; Davies, Sarah; Hicks, Debbie; Brown, Pam; Yousef, Zaheer; Dashora, Umesh; Viljoen, Adie; Beba, Hannah; Strain, W David.

Afiliação

Evans M; Diabetes Resource Centre, University Hospital Llandough, Penlan Road, Llandough, Cardiff, CF64 2XX, UK. marclyndon1@hotmail.com.
Morgan AR; Health Economics and Outcomes Research Ltd., Cardiff, UK.
Bain SC; Diabetes Research Unit, Swansea University Medical School, Swansea, UK.
Davies S; Woodlands Medical Centre, Cardiff, UK.
Hicks D; Medicus Health Partners, Enfield, London, UK.
Brown P; SA1 Medical Centre, Swansea, UK.
Yousef Z; Wales Heart Research Institute, Cardiff University, Cardiff, UK.
Dashora U; East Sussex Healthcare NHS Trust, Seaford, UK.
Viljoen A; East and North Hertfordshire NHS Trust, Stevenage, UK.
Beba H; County Durham and Darlington NHS Foundation Trust, Durham, UK.
Strain WD; Diabetes and Vascular Research Centre, University of Exeter Medical School, Exeter, UK.

Diabetes Ther ; 13(2): 225-240, 2022 Feb.

Article em En | MEDLINE | ID: mdl-35044569

Palavras-chave

Glucagon-like peptide-1 receptor agonists; Oral semaglutide; Type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Diabetes Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google